c.i. 42510 has been researched along with Thyroid Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beck-Sickinger, A; Berger, K; Führer, D; Ihling, C; Kalkhof, S; Paschke, R; Sinz, A; Wissmann, D | 1 |
| Dixon, E; McKinnon, JG; Pasieka, JL | 1 |
1 trial(s) available for c.i. 42510 and Thyroid Diseases
| Article | Year |
|---|---|
Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms.
Topics: Adult; Aged; Coloring Agents; Diagnosis, Differential; Feasibility Studies; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Rosaniline Dyes; Sensitivity and Specificity; Sentinel Lymph Node Biopsy; Thyroid Diseases; Thyroid Neoplasms | 2000 |
1 other study(ies) available for c.i. 42510 and Thyroid Diseases
| Article | Year |
|---|---|
Quantitative proteome analysis in benign thyroid nodular disease using the fluorescent ruthenium II tris(bathophenanthroline disulfonate) stain.
Topics: Dextrans; Electrophoresis, Gel, Two-Dimensional; Fluorescent Dyes; Humans; Indicators and Reagents; Peptide Mapping; Phenanthrolines; Proteome; Rhodamines; Rosaniline Dyes; Ruthenium Compounds; Silver Staining; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staining and Labeling; Thyroid Diseases; Thyroid Gland; Trypsin | 2004 |